These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 25916569)

  • 61. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study.
    Bhavnani SP; Pavuluri V; Coleman CI; Guertin D; Yarlagadda RK; Clyne CA; Kluger J
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):878-84. PubMed ID: 23614760
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predictors of successful defibrillation threshold test during CRT-D implantation.
    Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
    Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical Outcomes in Patients with Severe Renal Dysfunction Including Dialysis Following Defibrillator Implantation.
    Bogdan S; Nof E; Eisen A; Sela R; Rosenheck S; Freedberg N; Geist M; Ben-Zvi S; Haim M; Glikson M; Goldenberg I; Suleiman M;
    Am J Nephrol; 2015; 42(4):295-304. PubMed ID: 26529418
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
    Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
    Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Major predictors of fibrous adherences in transvenous implantable cardioverter-defibrillator lead extraction.
    Segreti L; Di Cori A; Soldati E; Zucchelli G; Viani S; Paperini L; De Lucia R; Coluccia G; Valsecchi S; Bongiorni MG
    Heart Rhythm; 2014 Dec; 11(12):2196-201. PubMed ID: 25111324
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.
    Barsheshet A; Moss AJ; Huang DT; McNitt S; Zareba W; Goldenberg I
    J Am Coll Cardiol; 2012 Jun; 59(23):2075-9. PubMed ID: 22651863
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study.
    Kramer DB; Mitchell SL; Monteiro J; Jones PW; Normand SL; Hayes DL; Reynolds MR
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25979902
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term performance and lead failure analysis of the Durata defibrillation lead compared to its previous model, the recalled Riata defibrillation lead.
    Kleemann T; Nonnenmacher F; Strauss M; Kouraki K; Werner N; Fendt A; Zahn R
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):2012-2019. PubMed ID: 31332876
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incidence of very high defibrillation thresholds (DFT) and efficacy of subcutaneous (SQ) array insertion during implantable cardioverter defibrillator (ICD) implantation.
    Verma A; Kaplan AJ; Sarak B; Oosthuizen R; Beardsall M; Higgenbottam J; Wulffhart Z; Khaykin Y
    J Interv Card Electrophysiol; 2010 Nov; 29(2):127-33. PubMed ID: 20865309
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term follow-up of patients supplied with single-chamber or dual-chamber cardioverter defibrillators.
    Kolb C; Deisenhofer I; Schmieder S; Barthel P; Zrenner B; Karch MR; Schmitt C
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):946-52. PubMed ID: 16981917
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prospective long-term evaluation of Optim-insulated (Riata ST Optim and Durata) implantable cardioverter-defibrillator leads.
    Cairns JA; Epstein AE; Rickard J; Connolly SJ; Buller C; Wilkoff BL; Pogue J; Themeles E; Healey JS
    Heart Rhythm; 2014 Dec; 11(12):2156-62. PubMed ID: 25131665
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of longevity and clinical outcomes of implantable cardioverter-defibrillator leads among manufacturers.
    Kawada S; Nishii N; Morimoto Y; Miyoshi A; Tachibana M; Sugiyama H; Nakagawa K; Watanabe A; Morita H; Ito H
    Heart Rhythm; 2017 Oct; 14(10):1496-1503. PubMed ID: 28502870
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Factors predicting Sprint Fidelis lead fracture: Results at 5 years from a French multicentre registry.
    Piot O; Deballon R; Nitu D; Marquié C; da Costa A; Leclercq C; Defaye P; Sadoul N
    Arch Cardiovasc Dis; 2015 Apr; 108(4):220-6. PubMed ID: 25858538
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The implantable cardioverter defibrillator: modern implantation techniques and their impact on outcomes.
    Luceri RM; Zilo P; Weiss DN
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():129-33. PubMed ID: 8734174
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Implantable cardioverter-defibrillator lead failure in children and young adults: a matter of lead diameter or lead design?
    Janson CM; Patel AR; Bonney WJ; Smoots K; Shah MJ
    J Am Coll Cardiol; 2014 Jan; 63(2):133-40. PubMed ID: 24140671
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Unscheduled Emergency Visits after Cardiac Devices Implantation: Comparison between Cardioverter Defibrillators and Cardiac Resynchronization Therapy Devices in less than one year of Follow Up.
    Warpechowski Neto S; Ley LLG; Almeida ED; Saffi MAL; Dutra LZ; Ley ALG; Sant'Anna RT; Lima GG; Kalil RAK; Leiria TLL
    Arq Bras Cardiol; 2019 May; 112(5):491-498. PubMed ID: 30810607
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.
    van der Heijden AC; Borleffs CJ; Buiten MS; Thijssen J; van Rees JB; Cannegieter SC; Schalij MJ; van Erven L
    Heart Rhythm; 2015 Jun; 12(6):1169-76. PubMed ID: 25749138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.